Home / Available CME / HIV Grand Rounds UPenn
Jointly Sponsored by
March 1st, 2012
March 15th, 2012
March 22nd, 2012
March 29th, 2012
April 5th, 2012
April 12th, 2012
April 19th, 2012
April 26th, 2012
May 3rd, 2012
May 10th, 2012
May 17th, 2012
May 24th, 2012
May 31st, 2012
June 7th, 2012
June 14th, 2012
HIV Grand Rounds - Home Page
Jointly Sponsored by 
and 
Series Overview
Target Audience
Commercial Support Acknowledgement
Learning Objectives for the Series
Course Directors
Faculty
Session Schedule and Participation Information
Live Session Topics and Speakers
Archived Curriculum Catalog
Hardware/Software Notice
Accreditation Statement/Credit Designation Statement
Disclosures
Disclosure of Unlabeled Use
Disclaimer
Target Audience
Commercial Support Acknowledgement
Learning Objectives for the Series
Course Directors
Faculty
Session Schedule and Participation Information
Live Session Topics and Speakers
Archived Curriculum Catalog
Hardware/Software Notice
Accreditation Statement/Credit Designation Statement
Disclosures
Disclosure of Unlabeled Use
Disclaimer
Series Overview:
The Perelman School of Medicine at the University of Pennsylvania and ViralEd are proud to announce the extension of this ground-breaking CME activity. Mirroring academic grand rounds programs, these CME-certified sessions combine traditional academic grand rounds with the innovation and convenience of telemedicine. The "HIV Grand Rounds from the Perelman School of Medicine at the University of Pennsylvania" is delivered live via the Internet every Thursday at noon (12 PM) Eastern Time and is available for on-demand viewing 24 hours following the live broadcast.
Presentations cover the most important and current topics in HIV/AIDS and are delivered by the top experts in the field. They are designed to be immediately relevant to practicing HIV clinicians and many are case-based. The final 10 minutes of each one-hour educational activity consists of a live question and answer period, with the presenting faculty member available to answer questions asked by attendees using the webinar interface. These weekly grand rounds are intended to provide clinicians with convenient and easily accessible knowledge and clinical skills they need to provide the best medical care for their HIV-positive patients.
Each session may be broadcast via your Internet connection in your conference room or auditorium for large groups to view, or individually to your personal computer at your convenience. Simply register at www.viraled.com/grandrounds for easy access.
Back to Top
Target Audience:
This educational activity is designed for HIV specialists, Infectious Disease specialists, Internal Medicine specialists, Family Practice physicians, Dermatologists, Osteo-specialists, Nephrologists, Hematology/oncologists, Psychiatrists, Public Health professionals, OB/GYN physicians and other clinicians interested and involved in the care of patients with HIV/AIDS.
Back to Top
Commercial Support Acknowledgement:
These activities are supported by educational grants from Gilead Sciences and Janssen Therapeutics.
Back to Top
Learning Objectives for the Series:
Back to Top
Learning Objectives for the Series:
Upon completion of the educational activity, participants should be able to:
-
List the important factors that play a role in ARV therapy success;
-
Explain the role that drug adverse events, drug pharmacokinetics and patient adherence play in achieving ARV success and avoiding morbidity and mortality;
-
Describe the important opportunistic infections and co-morbidities that may affect HIV-positive patients and increase their risk for morbidity and mortality;
-
Discuss the importance of individualizing the care of each HIV-positive patient.
Back to Top
Course Directors:
 |
John Bartlett, MD |
 |
Calvin J. Cohen, MD, MS |
 |
Ian Frank, MD |
Upcoming Faculty:
|
Peter Hunt MD |
|
Session Schedule and Participation Information:
-
Live 12:00 PM ET Thursdays or Anytime On-Demand
-
Delivered via webinar directly to you and/or your clinic.
-
You, or your clinic's coordinator, will receive a weekly email with topic, speaker, webinar link and participation pass-codes.
-
Sessions can be viewed in a large conference room or auditorium for large group viewing and participation, or directly on your personal computer.
-
If CME credit is desired for any of these sessions, proceed to http://penncmeonline.com/user/register to create your personal CME account. After your account is established this one time, following each session simply text the session code listed in the presentation slides to receive your CME credit.
Back to Top
Live Session Topics and Speakers:
|
|
|
|
Upcoming programs:
March 1st, 2012
Speaker: TBD
Topic: Real Cases from the Hospital of the University of Pennsylvania
March 15th, 2012
Speaker: Domenico Mavilio, MD, PhD
Topic: Natural Cytotoxicity Receptors: New Insights on Their Role in the Context of g/d T-cell Responses
March 22nd, 2012
Speaker: Ian Frank, MD
Topic: CROI Update
March 29th, 2012
Speaker: TBD
Topic: TBD
April 5th, 2012
Speaker: TBD
Topic: Real Cases from the Hospital of the University of Pennsylvania
April 12th, 2012
Speaker: TBD
Topic: TBD
April 19th, 2012
Speaker: Lawrence Corey, MD
Topic: HIV Vaccines
April 26th, 2012
Speaker: Paul Sax, MD
Topic: Initiating HIV Therapy
May 3rd, 2012
Speaker: TBD
Topic: EASL Update
May 10th, 2012
Speaker: Myron S. Cohen, MD
Topic: HIV Prevention
May 17th, 2012
Speaker: TBD
Topic: TBD
May 24th, 2012
Speaker: TBD
Topic: Real Cases from the Hospital of the University of Pennsylvania
May 31st, 2012
Speaker: Susan Barnett, PhD
Topic: Strategies for HIV Vaccine Development
June 7th, 2012
Speaker: TBD
Topic: TBD
June 14th, 2012
Speaker: TBD
Topic: TBD
Twenty four hours after the live broadcast, each program will become available for on-demand viewing and CME credit for one year.
The 26 one-hour lectures that ran in the pilot series from September 29, 2010 - May 4, 2011 are available here for viewing and CME credit.
ATTENTION: After selecting a session to view you will be taken to a short form. If you have logged on to ViralEd.com the form will be prepopulated where only one question, related to the number of participants, is left blank. Once this short form has been filled out and the "Go To Program" button has been pressed you will be taken directly to the program, which will commence immediately.
Back to Top
Hardware/Software Notice:
You will need Internet to participate in this activity.
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Perelman School of Medicine at the University of Pennsylvania and ViralEd, LLC. The Perelman School of Medicine at the University of Pennsylvania is accredited by the ACCME to provide continuing medical education for physicians.
Back to Top
Credit Designation Statement:
The Perelman School of Medicine at the University of Pennsylvania designates each live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Back to Top
Disclosures:
It is policy at the Perelman School of Medicine at the University of Pennsylvania and ViralEd, LLC for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania (Rodman Campbell, Mila Kostic, Belinda Rose, and Mindy Pollock Troy), our educational partner ViralEd, LLC (Richard Gordon, Brian Boyle, MD, JD and Ed Hettman), and the peer reviewer, Zalman Agus, MD, Associate Dean for Continuing Medical Education, have reported that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.
The following faculty or planning committee members have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
| John Bartlett, MD |
The following faculty or planning committee members have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity:
| Name | Commercial Supporter | Relationship |
| Calvin Cohen, MD | Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; ViiV | Contracted Research |
| Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec; Abbott | Consulting Fees | |
| Gilead; Bristol-Myers Squibb; Merck & Co.; Tibotec (all ceased 1 Jan 2011) | Speakers Bureaus | |
|
|
|
|
| Ian Frank, MD | GlaxoSmithKline | Contracted Research |
| Gilead | Consulting Fees | |
|
|
|
|
| Peter Hunt MD | Merck | Consultant |
| Pfixer, Salix, Roche | Investigator-Initiated Study | |
| Boehringer-Ingelheim, Gilead | Speaker | |
|
|
|
|
|
|
|
|
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ViralEd, LLC, the Perelman School of Medicine at the University of Pennsylvania, Gilead Sciences and JanssenTherapeutics do not recommend the use of any agent outside of the labeled indications.The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of ViralEd, LLC, the University of Pennsylvania School of Medicine, Gilead Sciences and Janssen Therapeutics. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Back to Top
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Back to Top
|
|
|
You may contact Richard Gordon by phone at 1-856-506-5790 or by email at Rgordon@viraled.com for additional assistance.
For CME questions please contact the Perelman School of Medicine at the University of Pennsylvania Office of CME: penncme@mail.med.upenn.edu.
We look forward to bringing the highest-quality CME directly to you.
| |
|
Share this page:
